Who Paid My Doc
Optisure Lead Post Approval Study
ClinicalTrials.gov NCT02235545
Research payments
$246,448
Through program year 2020, $246,448 in research payments was reported against Optisure Lead Post Approval Study, across 237 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT02235545
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $246,448 | 237 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gregory Olsovsky Temple, TX Named on 9 payments
- David Fitzgerald High Point, NC Named on 8 payments
- Jeffrey Kerlan Memphis, TN Named on 8 payments
- Daniel Schneider Mechanicsville, VA Named on 8 payments
- Devi Nair Jonesboro, AR Named on 7 payments
- Mohamed Djelmami Hani Grafton, WI Named on 7 payments
- Farhad Farokhi Rockford, IL Named on 7 payments
- Denise Sorrentio Ames, IA Named on 7 payments
- Ashish Sadhu Phoenix, AZ Named on 7 payments
- Darius Sholevar Cherry Hill, NJ Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.